PTAB Litigation Blog
  • Home
  • Cookie Policy
  • About
  • Advanced Topics
  • Contributors
  • Contacts
  • Design Patents
  • Discovery
  • District Court
  • Joinder
Select Page
Fed. Cir. Dissent: Opening Brief Lacking Appointments Clause Mention Still Eligible for Remand

Fed. Cir. Dissent: Opening Brief Lacking Appointments Clause Mention Still Eligible for Remand

by Tim Heverin | Nov 27, 2019 | Federal Circuit Appeal

By Emma Murray and Tim Heverin Last week, the Federal Circuit denied a motion to vacate and remand an IPR decision under Arthrex, Inc. v. Smith & Nephew, Inc.    Issued on October 31, Arthrex held that the method for appointing PTAB Administrative Patent Judges...
Federal Circuit Three Times More Likely to Rule 36 Patent Owner-Appellants

Federal Circuit Three Times More Likely to Rule 36 Patent Owner-Appellants

by Carl Kukkonen | Nov 25, 2019 | Federal Circuit Appeal

By Austin Ball and Carl Kukkonen When patent owners appeal PTAB decisions to the Federal Circuit, 67% of subsequent opinions are one-line Federal Circuit Rule 36 (“Rule 36”) summary affirmance orders, but when petitioners appeal, that number is a mere 18%.  Chestnut...
Notes from House Judiciary Subcommittee Hearing on Arthrex

Notes from House Judiciary Subcommittee Hearing on Arthrex

by Matthew Johnson | Nov 21, 2019 | Federal Circuit Appeal, PTAB News

By Marlee Hartenstein and Matt Johnson On Tuesday, the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, and the Internet conducted a hearing to discuss recent court decisions, namely the Federal Circuit’s decision in Arthrex.  Previously...
Government to Request Arthrex Rehearing; Rush for Remands Slowed

Government to Request Arthrex Rehearing; Rush for Remands Slowed

by Joe Sauer | Nov 20, 2019 | Federal Circuit Appeal, PTAB News

By Robby Breetz and Joe Sauer On October 31, 2019 a panel of Federal Circuit Judges issued the Arthrex Inc. v. Smith and Nephew, Inc. opinion finding the appointment of PTAB judges unconstitutional by violating the Appointments Clause.  The panel’s remedy in that case...
Federal Circuit Requests Additional Arthrex Appointments Clause Briefing

Federal Circuit Requests Additional Arthrex Appointments Clause Briefing

by Matthew Johnson | Nov 15, 2019 | Federal Circuit Appeal, PTAB News

By Matt Johnson Following up on a November 4th oral argument (accessible here) that focused on the Arthrex Appointments Clause issue, the Federal Circuit has requested additional briefing from Polaris, Kingston, and the U.S. regarding the proper remedy for the Arthrex...
Federal Circuit Says Appointment of PTAB Judges Unconstitutional

Federal Circuit Says Appointment of PTAB Judges Unconstitutional

by Matthew Johnson | Nov 5, 2019 | Federal Circuit Appeal, PTAB News

By Marlee Hartenstein and Matt Johnson Last Thursday, the Federal Circuit found the appointments of Patent Trial and Appeal judges unconstitutional, in part because the judges do not receive sufficient oversight from the Director of the United States Patent and...
« Older Entries
Next Entries »

About this blog

Categories

  • 325(d) issues
  • Amendment Practice
  • CBMs
  • Claim Construction
  • Design Patents
  • Discovery
  • District Court
  • Estoppel
  • Evidentiary Issues
  • Expert Witnesses
  • Federal Circuit
  • Federal Circuit Appeal
  • Final Written Decisions
  • Joinder
  • Motions Practice
  • Other News
  • Patent Eligible Subject Matter
  • Petitions
  • PGR
  • Pharmaceutical
  • Preliminary Responses
  • Prior Art Issues
  • PTAB News
  • PTAB Trial Basics
  • Real Party in Interest
  • Request for Reconsideration
  • Standing
  • Stay
  • Time Limits
  • Trial Institution
  • Uncategorized

Archives

Links

www.jonesday.com

About Jones Day's Intellectual Property Practice

Subscribe to Jones Day publications

    • Privacy
    • X
    • RSS

    The opinions expressed are those of the authors and do not necessarily reflect the views of Jones Day or its clients. The posts and information provided are for general information purposes and are not intended to be and should not be taken as legal advice.